Association of Non-LDL Indices with Recurrent Stroke Risk while on Lipid-Modifying Therapy
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Atherosclerosis and Thrombosis"
DOI: 10.5551/jat.49304
Abstract: Aims: Low-density lipoprotein (LDL)-lowering statin therapy is an established secondary stroke prevention strategy. However, the differential impact of key non-LDL levels on recurrent stroke risk, while on lipid-modifying therapy (LT), remains unclear. Methods: We analyzed… read more here.
Keywords: risk; recurrent stroke; level; level level ... See more keywords